Related Experiment Video

Updated: May 20, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Effects of activin and TGFβ on p21 in colon cancer

Jessica Bauer1, Judith C Sporn, Jennifer Cabral

  • 1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.

Plos One
|July 5, 2012
PubMed

Insights

Activin and TGFβ differentially regulate p21 in colon cancer. Activin promotes apoptosis and migration via p21 downregulation, while TGFβ induces growth arrest via p21 upregulation, impacting cancer progression.

Area of Science:

  • Cell biology
  • Molecular oncology
  • Cancer signaling pathways

Background:

  • Colon cancer involves complex signaling pathways, including Activin and Transforming Growth Factor-beta (TGFβ).
  • These pathways, sharing SMAD signaling, can be inactivated in colon cancer, but their distinct roles remain unclear.
  • p21 (CDK-interacting protein 1/WAF1) is a known TGFβ target, but its regulation by Activin is not well understood.

Purpose of the Study:

  • To dissect the differential effects of Activin and TGFβ signaling on p21 regulation and function in colon cancer.
  • To investigate the mechanisms underlying Activin-induced p21 modulation.
  • To explore the functional consequences of differential p21 regulation by Activin and TGFβ in colon cancer progression.

Main Methods:

  • Cellular assays to assess growth suppression, apoptosis, and migration.
  • Western blotting and proteasomal degradation assays to evaluate p21 protein levels and regulation.
  • SMAD4-dependent and -independent pathway analyses.
  • Analysis of p21 expression in primary colon cancer tissues.

Main Results:

  • TGFβ is a more potent inducer of growth suppression, while Activin is a more potent inducer of apoptosis.
  • Activin downregulates p21 protein via SMAD4-independent ubiquitination and proteasomal degradation, enhancing migration.
  • TGFβ upregulates p21 protein in a SMAD4-dependent manner, promoting growth arrest.
  • Activin-induced effects are p21-dependent for growth suppression/cell death but p21-antagonized for migration.
  • Differential p21 expression in colon cancers correlates with receptor status (ACVR2/TGFBR2).

Conclusions:

  • p21 acts as a differentially regulated target of Activin and TGFβ signaling in colon cancer.
  • Activin and TGFβ signaling mediate distinct cellular functions through ligand-specific p21 modulation.
  • Understanding these differential roles of p21 could aid in colon cancer risk stratification and therapeutic strategies.

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...